MX2016008780A - Derivados de sultam heteroarilo como moduladores del receptor huerfano relacionado con el acido retinoico gamma (ror gamma). - Google Patents

Derivados de sultam heteroarilo como moduladores del receptor huerfano relacionado con el acido retinoico gamma (ror gamma).

Info

Publication number
MX2016008780A
MX2016008780A MX2016008780A MX2016008780A MX2016008780A MX 2016008780 A MX2016008780 A MX 2016008780A MX 2016008780 A MX2016008780 A MX 2016008780A MX 2016008780 A MX2016008780 A MX 2016008780A MX 2016008780 A MX2016008780 A MX 2016008780A
Authority
MX
Mexico
Prior art keywords
heteroaryl
sultam derivatives
rorc modulators
rorc
modulators
Prior art date
Application number
MX2016008780A
Other languages
English (en)
Inventor
Fauber Benjamin
Rene Olivier
Yajima Herbert
Malhotra Sushant
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2016008780A publication Critical patent/MX2016008780A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Abstract

Los compuestos de la fórmula I o una sal farmacéutica de los mismos, en donde m, n, q, r, A, W, X1, X2, X3, X4, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 y R11 son como se definen en el presente documento. También se describen métodos de preparación de los compuestos y el uso de los compuestos para el tratamiento de enfermedades inflamatorias tales como artritis.
MX2016008780A 2014-01-10 2015-01-09 Derivados de sultam heteroarilo como moduladores del receptor huerfano relacionado con el acido retinoico gamma (ror gamma). MX2016008780A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461925831P 2014-01-10 2014-01-10
PCT/EP2015/050290 WO2015104353A1 (en) 2014-01-10 2015-01-09 HETEROARYL SULTAM DERIVATIVES AS RORc MODULATORS

Publications (1)

Publication Number Publication Date
MX2016008780A true MX2016008780A (es) 2016-09-08

Family

ID=52396653

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008780A MX2016008780A (es) 2014-01-10 2015-01-09 Derivados de sultam heteroarilo como moduladores del receptor huerfano relacionado con el acido retinoico gamma (ror gamma).

Country Status (9)

Country Link
US (1) US20160311817A1 (es)
EP (1) EP3092237A1 (es)
JP (1) JP2017502070A (es)
KR (1) KR20160106165A (es)
CN (1) CN105899506A (es)
CA (1) CA2933391A1 (es)
MX (1) MX2016008780A (es)
RU (1) RU2016131356A (es)
WO (1) WO2015104353A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2760521T3 (es) 2014-01-10 2020-05-14 Hoffmann La Roche Derivados de aril-sultamo como moduladores de RORc
JP6458041B2 (ja) * 2014-01-10 2019-01-23 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ＲＯＲｃモジュレーターとしてのアリールスルタム誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013064231A1 (en) * 2011-10-31 2013-05-10 Phenex Pharmaceuticals Ag SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
US9216988B2 (en) * 2011-12-22 2015-12-22 Genentech, Inc. Benzyl sulfonamide derivatives as RORc modulators
PE20150229A1 (es) * 2012-05-31 2015-03-02 Phenex Pharmaceuticals Ag Tiazoles sustituidos por carboxamida o sulfonamida y derivados relacionados como moduladores para el receptor nuclear huerfano rory

Also Published As

Publication number Publication date
EP3092237A1 (en) 2016-11-16
WO2015104353A1 (en) 2015-07-16
CA2933391A1 (en) 2015-07-16
CN105899506A (zh) 2016-08-24
RU2016131356A (ru) 2018-02-16
US20160311817A1 (en) 2016-10-27
KR20160106165A (ko) 2016-09-09
JP2017502070A (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
PH12014502788A1 (en) ARYL SULTAM DERIVATIVES AS RORc MODULATORS
PH12018502136A1 (en) Heterocyclic amides useful as protein modulators
MX2016008499A (es) Derivados de arilsultamo como moduladores del receptor huerfano relacionado con el receptor de retinoide (rorc).
MX2018002402A (es) Compuestos de heteroarilo o arilo biciclicos fusionados como moduladores de la quinasa 4 asociada al receptor de la interleucina 1 (irak4).
PH12016501972B1 (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
MX2017006266A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos.
TW201613911A (en) Heterocyclic compounds and uses thereof
MX2016015247A (es) Derivados de benceno-sulfonamida y su uso como moduladores del receptor c huerfano relacionado a acido retinoico (rorc).
TW201613872A (en) IRAK4 inhibiting agents
PH12017501523A1 (en) Selective bace1 inhibitors
GEP20207111B (en) Heteroaryl compounds for kinase inhibition
MA39749A (fr) Dérivés de pipéridine-dione
GEP20186933B (en) Substituted dihydroisoquinoline compounds
MX2015006926A (es) Derivados de bencil sulfonamida como moduladores del receptor huerfano relacionado con el receptor retinoide (rorc).
MX2016008721A (es) Derivados de aril sultama como moduladores del receptor huerfano relacionado con acido retinoico (rorc).
MX2016005128A (es) Derivados de 5,6,7,8-tetahidro-5,8-metanocinolina como moduladores del receptor huerfano y relacionado con acido retinoico (rorc) para el tratamiento de enfermedades autoinmunes.
MX2015011180A (es) Derivados de aril sulfamida y sulfamato como moduladores del receptor huerfano relacionado con el receptor del retinoide (porc).
TW201613864A (en) Novel compounds
MX2016002718A (es) Derivados de ceto-imidazopiridina como moduladores del receptor huerfano relacionado con receptor retinoide (porc).
MX2017015743A (es) Moduladores de ror gamma (ror?).
PH12014501712A1 (en) Novel morpholinyl derivatives useful as mogat-2-inhibitors
MX2015015614A (es) Derivados de aril sultama como moduladores del receptor huerfano relacionado con el receptor del retinoide (rorc).
MX2016010877A (es) Amidas antimitoticas para el tratamiento del cancer y desordenes proliferativos.
PH12016502568B1 (en) Novel heterocyclic compound
PH12018500668A1 (en) Therapeutic compounds and methods of use thereof